Skip to main navigation Skip to search Skip to main content

Control problems arising in cancer chemotherapy under evolving drug resistance - Finite versus infinite dimensional models

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

This paper presents comparison of two classes of systems used in modelling of cancer chemotherapy. They combine models that so far have been studied separately, taking into account both the phenomenon of gene amplification and cycle specificity in chemotherapy, in their different aspects. The methodology of analysis of such models, based on system decomposition, is discussed. In the infinite dimensional model, the mathematical description is given by an infinite number of state equations with a system matrix, which form allows decomposing the model into two interacting subsystems. While the first one, of finite dimension, can have any form, the second one is infinite dimensional and tridiagonal. The finite dimensional model on the other hand takes into account only two levels of drug resistance but it allows for more rigorous mathematical analysis. The optimal control problem is defined in l1 space.

Original languageEnglish
Title of host publication2007 European Control Conference, ECC 2007
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages3103-3108
Number of pages6
ISBN (Electronic)9783952417386
DOIs
Publication statusPublished - 2007
Event2007 9th European Control Conference, ECC 2007 - Kos, Greece
Duration: 2 Jul 20075 Jul 2007

Publication series

Name2007 European Control Conference, ECC 2007

Conference

Conference2007 9th European Control Conference, ECC 2007
Country/TerritoryGreece
CityKos
Period2/07/075/07/07

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Control and Systems Engineering

Fingerprint

Dive into the research topics of 'Control problems arising in cancer chemotherapy under evolving drug resistance - Finite versus infinite dimensional models'. Together they form a unique fingerprint.

Cite this